Carboxyamidotriazole
Carboxyamidotriazole[edit]
Carboxyamidotriazole (CAI) is a small molecule inhibitor that has been studied for its potential use in cancer therapy. It is known for its ability to interfere with calcium signaling pathways, which are crucial for various cellular processes, including cell proliferation, angiogenesis, and metastasis.
Mechanism of Action[edit]
Carboxyamidotriazole functions primarily by inhibiting non-voltage-operated calcium channels in the cell membrane. This inhibition leads to a decrease in intracellular calcium levels, which in turn affects several downstream signaling pathways. The reduction in calcium influx can inhibit the activation of protein kinase C and other calcium-dependent enzymes, ultimately leading to reduced cell proliferation and angiogenesis.
Therapeutic Applications[edit]
Carboxyamidotriazole has been investigated for its potential use in treating various types of cancer, including breast cancer, lung cancer, and glioblastoma. Its ability to inhibit angiogenesis makes it a promising candidate for anti-cancer therapy, as it can potentially starve tumors of their blood supply, thereby inhibiting their growth and spread.
Pharmacokinetics[edit]
The pharmacokinetic profile of Carboxyamidotriazole involves its absorption, distribution, metabolism, and excretion. CAI is known to have a relatively long half-life, which allows for sustained inhibition of calcium channels. It is metabolized in the liver and excreted primarily through the kidneys.
Side Effects[edit]
As with many anti-cancer agents, Carboxyamidotriazole can have side effects. Commonly reported side effects include nausea, fatigue, and dizziness. More severe side effects may include hepatotoxicity and nephrotoxicity, which require careful monitoring during treatment.
Research and Development[edit]
Research on Carboxyamidotriazole is ongoing, with several clinical trials conducted to evaluate its efficacy and safety in cancer patients. Studies have shown that CAI can be used in combination with other chemotherapeutic agents to enhance its anti-cancer effects.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
